Li Kunwei, Liang Yiyu, Cheng Ao, Wang Qi, Li Ying, Wei Haocheng, Zhou Changzheng, Wan Xinhuan
College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355 China.
Qingdao University of Technology, Qingdao, 266033 China.
Rev Bras Farmacogn. 2021;31(4):408-419. doi: 10.1007/s43450-021-00182-1. Epub 2021 Oct 6.
Baicalin is one of the bioactive flavonoid glycosides isolated from the dried root of Georgi, Lamiaceae, with antiviral properties. In recent years, the antiviral activity of baicalin has been widely investigated to explore its molecular mechanism of action. In this mini-review, the molecular mechanisms of action of baicalin as an antiviral agent are evaluated, which included three categories: the inhibition or stimulation of JAK/STAT, TLRs, and NF-κB pathways; up or down modulation of the expression levels of IFN, IL, SOCS1/3, PKR protein, Mx1 protein, and AP-1 protein; and inhibition of cell apoptosis caused by virus infection. In addition, clinical studies of baicalin are also discussed. This literature search suggested that baicalin can serve as a potential candidate for the development of a novel broad-spectrum antiviral drug.
The online version contains supplementary material available at 10.1007/s43450-021-00182-1.
黄芩苷是从唇形科植物黄芩干燥根中分离出的具有生物活性的黄酮苷之一,具有抗病毒特性。近年来,人们对黄芩苷的抗病毒活性进行了广泛研究,以探索其分子作用机制。在本综述中,评估了黄芩苷作为抗病毒剂的分子作用机制,包括三类:对JAK/STAT、TLRs和NF-κB信号通路的抑制或刺激;上调或下调IFN、IL、SOCS1/3、PKR蛋白、Mx1蛋白和AP-1蛋白的表达水平;以及抑制病毒感染引起的细胞凋亡。此外,还讨论了黄芩苷的临床研究。该文献检索表明,黄芩苷可作为开发新型广谱抗病毒药物的潜在候选药物。
在线版本包含可在10.1007/s43450-021-00182-1获取的补充材料。